Visit Sclero Forums, Chats and Blogs!
 
Search sclero.org:
 
The most important thing in the world to know about
scleroderma is sclero.org with 5,000+ pages in 23 languages!
 
Donate in MemoryIn loving memory of Tom Regensburger, and Vera Kortan . (Donate)
Home   Medical   News   *Sclero Forums*   Support   Languages/Countries
Earn $150 on July 30th in Boston Marketing Research Study if you have scleroderma or CTD and have been screened for pulmonary hypertension!
Frog jumping for joy by Shelley EnszPDF Flyer: Boston Marketing Research Study. Schlesinger Associates-Boston, a national marketing research company, is currently looking for patients who have been diagnosed with Scleroderma or other Connective Tissue Disease, who either have pulmonary hypertension or who are regularly screened for it, to participate in a July 30th paid marketing research study in Boston. Read PDF Flyer: Boston Marketing Research Study or call Katherine at 617-542-5500 x310. Schlesinger Associates-Boston. Posted 07/26/10.
Scleroderma Newsroom
Janey WillisHello, I am Janey Willis, ISN News Director and ISN Asst. Webmaster. David Becker, ISN Assistant News Guide researches our Autoimmune News section. Jeannie McClelland, ISN Assistant News Guide, researches Scleroderma Medical and Media News. Assistant News Guide Lisa Bulman posts these stories to our Sclero Forums.
Scleroderma Medical News
Autoimmune News
Media Stories
New Personal Stories
ISN Website & Donation News

Media News by Date

January 2010
Blue fingers linked with breathlessness. The coincidence of recent-onset Raynaud's disease with the pulmonary findings suggested the possibility of a connective tissue disorder. Lawrence J. Kagen, MD. Clinical Advisor. 01/21/10. (Also see: Raynaud's)
Treating Panic Disorder on the Web. An online treatment system for patients suffering with panic disorder and anxiety problems combine biofeedback therapy with web technologies and allows patients and medical professionals to communicate effectively. ScienceDaily. 01/20/10. (Also see: Emotional Adjustment)
Watching TV Linked to Higher Risk of Death. One of the most surprising findings is that it isn't just couch potatoes who were affected—even for people who exercised regularly, the risk of death went up the longer they were in front of the TV. The problem was the prolonged periods of time spent sitting still. Ron Winslow. Wall Street Journal. 01/12/10.
New Resource Helps Meet Challenges of Caring for Loved Ones with Chronic Pain. Caregiver Cornerstones provides information, encouragement, and tools to help family caregivers meet the unique challenges of caring for loved ones suffering from chronic pain, such as making sure your loved one receives appropriate assessment and treatment of their pain. PRNewswire. 01/05/10. (Also see: Caregivers and Managing Pain)
Scleroderma (SSc). Finding out that a person has scleroderma can be a long and frustrating journey. Part of the reason for this is that few doctors see many cases of SSc. Another reason is that the medical definition of SSc is so complex, involving many symptoms that may appear at different times in different forms in different people. And in the early stages, SSc is easily mistaken for other connective tissue diseases, such as systemic lupus erythematosus, polymyositis and rheumatoid arthritis. Meggan Mackay, M.D., M.S., and Peter Barland. The Doctor Will See You Now. January, 2010. (Also see: Difficult Diagnosis)
Jefferson awarded multi-million dollar NIH grant. The Department of Neurology at Jefferson Medical College (JMC) of Thomas Jefferson University has been awarded a multi-million dollar grant from the National Institutes of Health (NIH) for the creation of a center of excellence to study autoimmune diseases from basic science research to its translation into clinical applications. Medical News Today. December 11, 2009.
25 Years in Arthritis: New Treatments, New Hope. Biologics, other advancements have helped those with the painful condition of Rheumatoid Arthritis. John Gever. ABC News / Health. 01/02/10. (Also see: Rheumatoid Arthritis)
Northwestern Scleroderma Program. More than 300,000 Americans suffer from scleroderma, a progressive autoimmune disease that predominantly affects young women. Scleroderma leads to hardening of the skin, lungs, blood vessels, and other organs. At the Northwestern Scleroderma Program, we provide comprehensive patient care and pursue research that will lead to more effective treatments, and ultimately, a cure. Northwestern University. December, 2009. (Also see: About Scleroderma)
Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms. The purpose of this study is to determine if Vascana, a novel topical formulation of nitroglycerin, is effective in the treatment and prevention of the symptoms associated with Raynaud's Phenomenon. This trial is currently recruiting. Verified by MediQuest Therapeutics, December 2009. clinicaltrials.gov. (Also see: Clinical Trials for Raynaud's)
 
Go to Scleroderma Media News: December 2009
 
SCLERO.ORG is brought to you by the nonprofit International Scleroderma Network (ISN). The ISN is a full-service nonprofit scleroderma charitable foundation providing stellar research, support, education and awareness for scleroderma and related illnesses, such as pulmonary hypertension.
  1. Post a message in Sclero Forums
  2. Email: isn@sclero.org
  3. English Email Form
  4. Español Email Form
  5. Italiano Email Form
International Scleroderma Network (ISN)
7455 France Ave So #266
Edina, MN 55435-4702
United States

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information: verify here.

Toll Free Hotline in U.S.
Hours: 9am-3pm CST only.
Please leave a complete message, in English.
1-800-564-7099
Direct Line
1-952-583-5735
We are also known as the Scleroderma from A to Z web site.
Privacy Policy, Financial Disclosure, and Disclaimer.
© Copyright 1998-2010 International Scleroderma Network
All Rights Reserved
 
Home   Donate   Medical   News   *Sclero Forums*   Support   Translations   Search